scispace - formally typeset
M

Michael McClelland

Researcher at University of California, Irvine

Publications -  376
Citations -  29109

Michael McClelland is an academic researcher from University of California, Irvine. The author has contributed to research in topics: Salmonella enterica & Salmonella. The author has an hindex of 79, co-authored 372 publications receiving 27627 citations. Previous affiliations of Michael McClelland include University of Illinois at Chicago & University of Georgia.

Papers
More filters
Journal ArticleDOI

WebArray: an online platform for microarray data analysis.

TL;DR: This work developed an online microarray data analysis platform, WebArray, for bench biologists to utilize these tools to explore data from single/dual color microarray experiments, and provides a user-friendly interface for accessing a wide range of key functions of limma and others.
Journal ArticleDOI

Persistent Infections by Nontyphoidal Salmonella in Humans: Epidemiology and Genetics

TL;DR: These results illuminate the overlooked clinical manifestation of persistent salmonellosis that can serve as a human reservoir for NTS infections and demonstrate mechanisms of in-host microevolution and exhibit their potential to shape Salmonella pathogenicity, antimicrobial resistance and host-pathogen interactions.
Journal ArticleDOI

Effect of site-specific methylation on restriction endonucleases and DNA modification methyltransferases.

TL;DR: An updated list of the sensitivities of 298 restriction endonucleases and 20 DNA methyltransferases to sitespecific modification at 4-methylcytosine ("HT), 5- methylcytOSine C, 5-hydroxymethylcyTosine OTM), and 6-methyladenine (^A) is presented.
Journal ArticleDOI

Progression and NSAID-induced apoptosis in malignant melanomas are independent of cyclooxygenase II.

TL;DR: It is concluded that Cox-II expression is not involved in the progression of MM, and NSAID-induced apoptosis in MM cell lines seems to follow pathways independent of Cox-ii, Nevertheless, Cox- II inhibitors are still candidates for therapy, though they act via an unknown mechanism.